Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial | Zendy

Estebán Martínez | Zendy; Ana González-Cordón | Zendy; Elena Ferrer | Zendy; Peré Domingo | Zendy; Eugènia Negredo | Zendy; Félix Gutiérrez | Zendy; Joaquín Portilla | Zendy; Adrián Curran | Zendy; Daniel Podzamczer | Zendy; Esteban Ribera | Zendy; Javier Murillas | Zendy; José I. Bernardino | Zendy; Ignacio de los Santos | Zendy; J. A. Cartón | Zendy; Joaquim Peraire | Zendy; Judit Pich | Zendy; R. Deulofeu | Zendy; Ignacio Pérez | Zendy; José M. Gatell | Zendy; Juan A. Arnaiz | Zendy; Helena Beleta | Zendy; David Vinuesa García | Zendy; Andrea Pejenaute | Zendy; Núria Ramos | Zendy; P. Arcaina | Zendy; L. Giner | Zendy; Silvia Elena Uribe Moya | Zendy; M. Pampliega | Zendy; G. Barrera | Zendy; Nerea Rozas | Zendy; María Saumoy | Zendy; Víctor Asensi | Zendy; Mar Masiá | Zendy; Sergio Padilla | Zendy; J. R. Ramos | Zendy; Catalina Robledano | Zendy; Jordi Puig | Zendy; José Ramón Arribas | Zendy; Juan Castro | Zendy; Jesús Sanz | Zendy; Mireia Cairó | Zendy; Pablo Velli | Zendy; David Dalmau | Zendy; Ana Lamas | Zendy; P Martí-Belda | Zendy; Fernando Dronda | Zendy; José Ramón Blanco | Zendy; Margarita Gutiérrez | Zendy; M. G. Mateo | Zendy; Elena Losada | Zendy; A.K.C. Prieto | Zendy; Antonio Antela | Zendy; Alicia de Luna Aguilar | Zendy; Montserrat Vargas | Zendy; Consuelo Viladés | Zendy; Francesc Vidal | Zendy; Manuel Crespo | Zendy; J.A. Arnaiz | Zendy; D. Garcia | Zendy; Natàlia Ramos | Zendy

Open Access

Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial

Author(s) -

Estebán Martínez,

Ana González-Cordón,

Elena Ferrer,

Peré Domingo,

Eugènia Negredo,

Félix Gutiérrez,

Joaquín Portilla,

Adrián Curran,

Daniel Podzamczer,

Esteban Ribera,

Javier Murillas,

José I. Bernardino,

Ignacio de los Santos,

J. A. Cartón,

Joaquim Peraire,

Judit Pich,

R. Deulofeu,

Ignacio Pérez,

José M. Gatell,

Juan A. Arnaiz,

Helena Beleta,

David Vinuesa García,

Andrea Pejenaute,

Núria Ramos,

P. Arcaina,

L. Giner,

Silvia Elena Uribe Moya,

M. Pampliega,

G. Barrera,

Nerea Rozas,

María Saumoy,

Víctor Asensi,

Mar Masiá,

Sergio Padilla,

J. R. Ramos,

Catalina Robledano,

Jordi Puig,

José Ramón Arribas,

Juan Castro,

Jesús Sanz,

Mireia Cairó,

Pablo Velli,

David Dalmau,

Ana Lamas,

P Martí-Belda,

Fernando Dronda,

José Ramón Blanco,

Margarita Gutiérrez,

M. G. Mateo,

Elena Losada,

A.K.C. Prieto,

Antonio Antela,

Alicia de Luna Aguilar,

Montserrat Vargas,

Consuelo Viladés,

Francesc Vidal,

Manuel Crespo,

J.A. Arnaiz,

D. Garcia,

Natàlia Ramos

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu898

Subject(s) - medicine , protease , randomized controlled trial , human immunodeficiency virus (hiv) , clinical trial , protease inhibitor (pharmacology) , virology , antiretroviral therapy , viral load , enzyme , biology , biochemistry

It is unclear whether metabolic or body composition effects differ between protease inhibitor-based regimens recommended for initial treatment of human immunodeficiency virus (HIV) infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research